Of importance, we observed that administration of sulfarotene had no impact on the frequency and functions of NK cells but improved the stemness shift of CRCs induced by TIGIT blockage and NK activation, highlighting the treatment efficacy of sulfarotene combined with immunological therapy in MMR-p CRC. This evidence concerns the gene TIGIT and colorectal carcinoma.